"10.1371_journal.pone.0089611","plos one","2014-02-26T00:00:00Z","Lisa L Ross; Joseph Horton; Samiul Hasan; James R Brown; Daniel Murphy; Edwin DeJesus; Martin Potter; Anthony LaMarca; Ivan Melendez-Rivera; Douglas Ward; Jonathon Uy; Mark S Shaefer","ViiV HealthCare, Research Triangle Park, North Carolina, United States of America; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; GlaxoSmithKline, Stevenage, United Kingdom; Clinique Medicale LActuel, Montreal, QC, Canada; Orlando Immunology Center, Orlando, Florida, United States of America; McGill University Health Centre, Montreal, QC, Canada; Therafirst Medical Center, Ft Lauderdale, Florida, United States of America; Centro Ararat, Ponce, Puerto Rico; Dupont Circle Physicians Group, Washington, DC, United States of America; Amicus Therapeutics, Cranbury, New Jersey, United States of America","Conceived and designed the experiments: LLR JRB MSS. Analyzed the data: LLR JH SH JRB. Contributed reagents/materials/analysis tools: JU. Wrote the paper: LLR JH SH JRB DM ED MP AL IMR DW JU MSS. Instrumental in the collection of clinical and viral sequence data used in the analysis and the databasing of this data: LLR JH DM ED MP AL IMR DW MSS.","L.L.R. and M.S.S. are employed by ViiV Healthcare, whose company partly funded this study. J.U. was employed by BristolMyers-Squibb during the initial data collection. J.H., S.H. and J.B. are employed by GlaxoSmithKline. J.U. is an employee of Amicus Therapeutics. There are no patents, products in development or marketed products to declare as this analysis was performed using samples that were collected prior to any study drug administration. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Lisa L Ross","LLR",12,TRUE,3,NA,4,12,TRUE,TRUE,FALSE,0,NA,FALSE
